World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
51
Citations
6992
World Ranking
17361
National Ranking
7134

Overview

Ranajit Pal is affiliated with Advanced Bioscience Laboratories in the United States. Their research spans several fields including Medicine and Immunology and Microbiology, with a strong focus on immunology as well as epidemiology and virology. The scientist's work addresses multiple topics such as HIV research and treatment, biomedical research and pathophysiology, neonatal health and biochemistry, reproductive system and pregnancy, immune cell function and interaction, immune responses and vaccinations, and virology and viral diseases.

Their publication record includes papers in notable journals and venues. These include:

  • Engagement of monocytes, NK cells, and CD4+ Th1 cells by ALVAC-SIV vaccination results in a decreased risk of SIVmac251 vaginal acquisition, 2020, PLoS Pathogens
  • Correction: ALVAC-HIV B/C candidate HIV vaccine efficacy dependent on neutralization profile of challenge virus and adjuvant dose and type, 2020, PLoS Pathogens
  • In vitro activity of cysteamine against SARS-CoV-2 variants, 2022, Molecular Genetics and Metabolism
  • Study of immunogenicity and efficacy against Omicron BA.5 of recombinant protein-based COVID-19 vaccine delivered by intramuscular and mucosal routes in nonhuman primates, 2024, Vaccine
  • In Vitro Activity of Cysteamine Against SARS-CoV-2 Variants, 2021, bioRxiv (Cold Spring Harbor Laboratory)

Frequent co-authors with whom Ranajit Pal has collaborated include Lauren Wattay, Maria Grazia Ferrari, Giacomo Gorini, Monica Vaccari, and Dallas R. Brown. The scientist's work is often published in venues such as PLoS Pathogens, Molecular Genetics and Metabolism, Vaccine, and bioRxiv.

The research topics Ranajit Pal investigates cover areas critical to understanding infectious diseases and immune responses, with specific emphasis on vaccine efficacy, viral variants, and immune cell interactions during viral infections. Their focus on both basic and applied research links immunological mechanisms with clinical challenges in infectious disease management and prevention.

Best Publications

  • Growth of macrophage-tropic and primary human immunodeficiency virus type 1 (HIV-1) isolates in a unique CD4+ T-cell clone (PM1): failure to downregulate CD4 and to interfere with cell-line-tropic HIV-1.

    P. Lusso;F. Cocchi;C. Balotta;P. D. Markham

  • ALVAC-SIV-gag-pol-env-Based Vaccination and Macaque Major Histocompatibility Complex Class I (A*01) Delay Simian Immunodeficiency Virus SIVmac-Induced Immunodeficiency

    R. Pal;D. Venzon;N. L. Letvin;S. Santra

  • Inhibition of HIV-1 Infection by the β-Chemokine MDC

    Ranajit Pal;Alfredo Garzino-Demo;Phillip D. Markham;Jennifer Burns

  • Cross-subtype antibody and cellular immune responses induced by a polyvalent DNA prime–protein boost HIV-1 vaccine in healthy human volunteers

    Shixia Wang;Jeffrey S. Kennedy;Kim West;David C. Montefiori

  • Antibodies with High Avidity to the gp120 Envelope Protein in Protection from Simian Immunodeficiency Virus SIVmac251 Acquisition in an Immunization Regimen That Mimics the RV-144 Thai Trial

    Poonam Pegu;Monica Vaccari;Shari Gordon;Brandon F. Keele

  • Prevention of vaginal SHIV transmission in macaques by a live recombinant Lactobacillus

    Laurel A Lagenaur;Brigitte E Sanders-Beer;Beda Brichacek;Ranajit Pal

  • Crosslinked HIV-1 envelope-CD4 receptor complexes elicit broadly cross-reactive neutralizing antibodies in rhesus macaques.

    Timothy Fouts;Karla Godfrey;Kathryn Bobb;David Montefiori

  • Polyvalent HIV-1 Env vaccine formulations delivered by the DNA priming plus protein boosting approach are effective in generating neutralizing antibodies against primary human immunodeficiency virus type 1 isolates from subtypes A, B, C, D and E

    Shixia Wang;Ranajit Pal;John R. Mascola;Te-Hui W. Chou

  • Impact of vaccine-induced mucosal high-avidity CD8+CTLs in delay of AIDS viral dissemination from mucosa

    Igor M. Belyakov;Vladimir A. Kuznetsov;Brian Kelsall;Dennis Klinman

  • Protection of macaques against vaginal SHIV challenge by systemic or mucosal and systemic vaccinations with HIV-envelope.

    Susan W Barnett;Indresh K Srivastava;Elaine Kan;Fengmin Zhou

  • Myristoylation of gag Proteins of HIV-1 Plays an Important Role in Virus Assembly

    Ranajit Pal;Marvin S. Reitz;Erwin Tschachler;R.C. Gallo

  • Role of oligosaccharides in the processing and maturation of envelope glycoproteins of human immunodeficiency virus type 1.

    Ranajit Pal;George M. Hoke;M. G. Sarngadharan

  • Immunization of rhesus macaques with a polyvalent DNA prime/protein boost human immunodeficiency virus type 1 vaccine elicits protective antibody response against simian human immunodeficiency virus of R5 phenotype

    Ranajit Pal;Shixia Wang;V.S. Kalyanaraman;B.C. Nair

  • Replicating Adenovirus-Simian Immunodeficiency Virus (SIV) Recombinant Priming and Envelope Protein Boosting Elicits Localized, Mucosal IgA Immunity in Rhesus Macaques Correlated with Delayed Acquisition following a Repeated Low-Dose Rectal SIVmac251 Challenge

    Peng Xiao;L. Jean Patterson;Seraphin Kuate;Egidio Brocca-Cofano

  • Balance of cellular and humoral immunity determines the level of protection by HIV vaccines in rhesus macaque models of HIV infection

    Timothy R. Fouts;Kenneth Bagley;Ilia J. Prado;Kathryn L. Bobb

  • A Replication-Competent Adenovirus-Human Immunodeficiency Virus (Ad-HIV) tat and Ad-HIV env Priming/Tat and Envelope Protein Boosting Regimen Elicits Enhanced Protective Efficacy against Simian/Human Immunodeficiency Virus SHIV89.6P Challenge in Rhesus Macaques

    Thorsten Demberg;Ruth H. Florese;Megan J. Heath;Kay Larsen

  • Mode of action of 5'-linked cholesteryl phosphorothioate oligodeoxynucleotides in inhibiting syncytia formation and infection by HIV-1 and HIV-2 in vitro.

    C. A. Stein;Ranajit Pal;A. L. Devico;G. Hoke

  • Quantitative evaluation of simian immunodeficiency virus infection using NASBA technology.

    Joseph W. Romano;Roxanne N. Shurtliff;Eric Dobratz;Andrew Gibson

  • Increased immune responses in rhesus macaques by DNA vaccination combined with electroporation

    Margherita Rosati;Antonio Valentin;Rashmi Jalah;Vainav Patel

  • Phosphorothioate oligodeoxycytidine interferes with binding of HIV-1 gp120 to CD4.

    C. A. Stein;L. M. Neckers;B. C. Nair;S. Mumbauer

Frequent Co-Authors

David C. Montefiori
David C. Montefiori Duke University
Vaniambadi S. Kalyanaraman
Vaniambadi S. Kalyanaraman North Shore University Hospital
Phillip D. Markham
Phillip D. Markham Northrop Grumman (United States)
Genoveffa Franchini
Genoveffa Franchini National Institutes of Health
David Venzon
David Venzon National Institutes of Health
Robert C. Gallo
Robert C. Gallo University of South Florida
Marjorie Robert-Guroff
Marjorie Robert-Guroff National Institutes of Health
M. G. Sarngadharan
M. G. Sarngadharan AkzoNobel (Netherlands)
Anthony L. DeVico
Anthony L. DeVico University of Maryland, Baltimore
Celia C. LaBranche
Celia C. LaBranche Duke University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Ranajit Pal

Trending Scientists

Recently Published Articles